Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 1,796 | 1,548 | 2,552 | 3,219 | 3,277 |
| Operating Income | -1,796 | -1,548 | -2,552 | -3,219 | -3,277 |
| Other Income | 450 | 374 | 219 | 72 | 5 |
| Pre-tax Income | -1,346 | -1,174 | -2,333 | -3,147 | -3,272 |
| Net Income Continuous | -1,346 | -1,174 | -2,333 | -3,147 | -3,272 |
| Net Income | $-1,346 | $-1,174 | $-2,333 | $-3,147 | $-3,272 |
| EPS Basic Total Ops | -1.08 | -0.96 | -1.92 | -2.64 | -2.76 |
| EPS Basic Continuous Ops | -1.12 | -0.98 | -1.94 | -2.62 | -2.73 |
| EPS Diluted Total Ops | -1.08 | -0.96 | -1.92 | -2.64 | -2.76 |
| EPS Diluted Continuous Ops | -1.12 | -0.98 | -1.94 | -2.62 | -2.73 |
| EBITDA(a) | $-1,767 | $-1,519 | $-2,524 | $-3,190 | $-3,249 |